First round of Abstract Submissions is open now..!
Don't miss the opportunity! Submit your abstract for the first round by December 15, 2025.
2nd International Conference on
Drug Discovery
October 12-13, 2026
Village Hotel Changi, Singapore
Call For
Paper
AI & ML in Drug Discovery
AI & ML in Drug Discovery
This session examines how machine learning (ML) and artificial intelligence (AI) are revolutionizing each phase of the drug discovery process. Modern algorithms, predictive modeling methods, and practical applications that improve target identification, speed up lead optimization, and lower the chance of clinical development failure will be examined by participants.
- Deep Learning
- Digital Health
- Generative AI
- Omics Data
- In Silico Drug Discovery
- Collaborative AI Platforms
Biologics and Advanced Therapeutics
Biologics and Advanced Therapeutics
This session delves into the most recent advances in the discovery, engineering, and delivery of biologics and innovative therapeutics. Attendees will look at the scientific, manufacturing, and regulatory hurdles of delivering complex treatments such as monoclonal antibodies, cell and gene therapies, RNA-based medications, and new protein scaffolds to patients.
- Monoclonal Antibodies
- mRNA Vaccines
- Protein Engineering
- Non-Viral Delivery Systems
- Formulation and Stability
Business and Commercial Aspects of Drug Discovery
Business and Commercial Aspects of Drug Discovery
This session looks at the critical commercial and strategic factors that influence the success of drug discovery projects. Attendees will learn about finance options, intellectual property strategies, alliances, market access plans, and the changing landscape of biotech entrepreneurship. The emphasis is on how scientific advances are transformed into commercially viable, patient-accessible medicines.
- Funding Strategies
- Venture Capital
- Licensing Deals
- Market Access
- Academia–Industry Collaboration
- Health Economics
Target Identification and Validation
Target Identification and Validation
This session focuses on one of the most fundamental and important steps of drug discovery: identifying biologically relevant targets and assessing their therapeutic potential. Attendees will learn about breakthrough technology, high-throughput techniques, and integrated biological approaches that improve target selection and lower late-stage failure rates.
- Functional Genomics
- RNA Interference
- Target Deconvolution
- Disease Mechanisms
- Genetic Models
- In Vitro/In Vivo Validation
Pharmacokinetics and Pharmacodynamics in Drugs
Pharmacokinetics and Pharmacodynamics in Drugs
The importance of pharmacokinetics (PK) and pharmacodynamics (PD) in comprehending drug behaviour, enhancing dosage schedules, and forecasting clinical results is discussed in this session. Participants will investigate cutting-edge modeling methods, experimental procedures, and translational tactics that enhance decision-making in preclinical, clinical, and discovery development.
- PK/PD Modeling
- Dose Optimization
- Bioanalytical Methods
- Preclinical to Clinical Bridging
- Simulation in Drug Development
Drug Safety and Pharmacovigilance
Drug Safety and Pharmacovigilance
The main topics of this session are the fundamental ideas and developing procedures for guaranteeing medication safety during the course of the product lifecycle. With a focus on enhancing patient outcomes and reducing risk, it will address regulatory requirements, real-world evidence, data-driven ways to monitor adverse events, and advancements in pharmacovigilance systems.
- Risk Management Plan
- Regulatory Compliance
- Patient Safety
- Drug Recall Case Studies
- Digital Safety Tools
Neurodegenerative & CNS Drug Discovery
Neurodegenerative & CNS Drug Discovery
This session addresses the unique scientific, clinical, and translational challenges of discovering and developing therapies for neurodegenerative and central nervous system (CNS) disorders. Participants will study novel targets, innovative modeling tools, and strategies to optimize translation from preclinical discoveries to clinical success.
- Alzheimer’s Disease
- Parkinson’s Disease
- Neuroinflammation
- Translational Research
- Case Studies in CNS Therapeutics
Natural Products and Novel Chemical Entities
Natural Products and Novel Chemical Entities
This session emphasizes the ongoing importance and innovation in discovering new medicinal agents from natural sources, as well as the design of novel chemical entities. Participants will learn about cutting-edge research in natural product isolation, synthetic modification, and de novo design, as well as advanced screening and analytical methods that help identify structurally distinct, bioactive molecules.
- High-Throughput Screening
- Synthetic Chemistry
- NMR/Mass Spectrometry
- De Novo Drug Design
- Supply and Scalability
Drug Repurposing and Combination Therapy
Drug Repurposing and Combination Therapy
This session explores innovative strategies for expanding treatment options and improving patient outcomes by repurposing existing drugs and developing rational combination therapies. Participants will discuss scientific, clinical, and regulatory considerations for identifying new indications, optimizing synergistic effects, and accelerating development timelines while reducing costs and risks.
- Computational Drug Discovery
- Oncology Combinations
- Data Mining for Repurposing
- Real-World Evidence
- Preclinical Validation
Preclinical Drug Development and Trial Design
Preclinical Drug Development and Trial Design
This session delves into the essential period of preclinical research, in which promising drug candidates are examined for safety, effectiveness, and pharmacological qualities prior to entering human trials. Attendees will look at cutting-edge techniques, regulatory expectations, and novel study designs that improve the predictive potential of preclinical research and translational success.
- In Vitro Models
- ADME Studies
- Safety Pharmacology
- First-in-Human Trials
- Animal Model Ethics
- Regulatory Requirements
Post Marketing Surveillance
Post Marketing Surveillance
This session investigates the critical role of post-marketing monitoring (PMS) in guaranteeing the long-term safety and efficacy of licensed medications. Participants will learn about best practices, regulatory requirements, and innovative methods for monitoring adverse events, assessing real-world outcomes, and preserving public faith in pharmacotherapy.
- Adverse Event Reporting
- Patient-Reported Outcomes
- Digital Health Monitoring
- Drug Safety Monitoring
- Lifecycle Management
Medicinal Chemistry Innovations
Medicinal Chemistry Innovations
This session highlights the latest developments, tools, and strategies in medicinal chemistry that are propelling the discovery of safer, more effective, and more selective therapeutic agents. Attendees will learn about modern synthetic approaches, structure-based design, and integrated technologies that expedite the process from hit identification to optimized drug candidate.
- Fragment-Based Drug Design
- Synthetic Methodologies
- PROTACs
- Molecular Modeling
- Scaffold Hopping
Regulatory Science & Drug Approval Strategies
Regulatory Science & Drug Approval Strategies
The changing regulatory environment, scientific frameworks, and tactical methods required to successfully negotiate drug approval procedures globally are the main topics of this session. Participants will examine international regulatory frameworks, data needs, and risk-benefit analysis that are critical to effectively and safely delivering novel treatments to patients.
- Regulatory Strategy
- FDA/EMA/PMDA Guidelines
- Risk–Benefit Assessment
- Safety Data Integration
- Lifecycle Management.
Rare Diseases & Precision Medicine
Rare Diseases & Precision Medicine
The scientific, clinical, and regulatory developments that are propelling innovation in the management of uncommon diseases and the development of individualized medicine are highlighted in this session. Participants will examine how drug development for small populations and tailored therapy is changing due to genetic insights, innovative trial designs, and patient-specific techniques.
- Orphan Drugs
- Precision Therapeutics
- Cell and Gene Therapy
- Rare Disease Registries
- Regulatory Acceleration
- Global Access & Equity
Drug Delivery Systems and Formulation
Drug Delivery Systems and Formulation
This session examines cutting-edge approaches and tools in formulation science and medication delivery that improve patient adherence, safety, and therapeutic efficacy. Advanced delivery methods, formulation design considerations, and practical applications that overcome biological barriers and maximize pharmacokinetics will all be covered for participants.
- Pharmaceutical Formulation
- Targeted Delivery
- Nanoparticles
- Smart Delivery Systems
- Manufacturing of Drug Products
Hit-to-Lead Optimization
Hit-to-Lead Optimization
The crucial stage of drug development, where promising screening hits are developed into premium lead compounds with optimal potency, selectivity, and drug-like qualities, is examined in this session. Participants will examine tried-and-true tactics, state-of-the-art resources, and actual case studies that show how successful hit-to-lead optimization lowers downstream attrition and speeds up preclinical success.
- Lead generation
- Multi-Parameter Optimization
- Virtual screening
- Medicinal Chemistry
- In Silico Modeling
- Preclinical Development
Case Studies & Late-Breaking Discoveries
Case Studies & Late-Breaking Discoveries
This dynamic discussion will highlight recent discoveries, new research, and real-world lessons from successful (and tough) drug discovery initiatives. Attendees will acquire valuable insights into the practical aspects of turning scientific findings into therapeutic prospects, with a focus on what worked, what didn't, and why.
- High-Throughput Screening
- Preclinical Successes
- Clinical Translation
- Academic–Industry Partnerships
- Breakthrough Therapies
- Innovation Stories
Translational Innovations in Drug Discovery
Translational Innovations in Drug Discovery
This session focuses on innovative approaches that move promising medication candidates from the bench to the bedside by bridging the gap between laboratory research and clinical application. In order to increase the effectiveness of converting scientific discoveries into efficient, patient-ready therapeutics, participants will examine cutting-edge methodologies, cooperative models, and enabling technology.
- Biomarker Development
- Preclinical Models
- Adaptive Trial Design
- Clinical Development
- Healthcare Innovation
+1-404-759-9729
